Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Edgewise Therapeutics, Inc. | EWTX | 3.7M | $150.4M |
Denali Therapeutics Inc. | DNLI | 3.73M | $96.05M |
GRAIL Inc. | GRAL | 4.03M | $275.03M |
Monte Rosa Therapeutics, Inc. | GLUE | 4.35M | $105.17M |
Nurix Therapeutics, Inc. | NRIX | 4.66M | $113.02M |
Roivant Sciences Ltd. | ROIV | 4.72M | $166.93M |
IDEAYA Biosciences, Inc. | IDYA | 5.01M | $186.72M |
Entrada Therapeutics, Inc. | TRDA | 5.07M | $37.34M |
Immunovant, Inc. | IMVT | 5.44M | $209.42M |
Rhythm Pharmaceuticals, Inc. | RYTM | 5.6M | $622.27M |
Cerus Corporation | CERS | 6.4M | $18.67M |
Celcuity Inc. | CELC | 7.92M | $828.15M |
Kymera Therapeutics, Inc. | KYMR | 8.66M | $992.73M |
Insmed Incorporated | INSM | 8.8M | $937.84M |
BeOne Medicines AG | ONC | 8.8M | $2.51B |
Alkermes plc | ALKS | 10.01M | $524.59M |
Replimune Group, Inc. | REPL | 11.05M | $122.27M |
Revolution Medicines, Inc. | RVMD | 11.44M | $2.14B |
Kodiak Sciences Inc. | KOD | 19.92M | $776.05M |
Incyte Corporation | INCY | 30.76M | $3.49B |